Sale!

VICTOZA (liraglutide recombinant) Drug Profile, 2024

Original price was: $1,199.00.Current price is: $699.00.

VICTOZA (liraglutide recombinant) drug patents, patent challenges, litigation, PTAB cases, SPCs, clinical trials, drug prices, drug prices, annual drug sames, suppliers, API sources

SKU: VICTOZA Category:
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

VICTOZA Drug Profile, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs.

This definitive guide provides invaluable business insights into every crucial aspect of this medication, addressing the vital points necessary to make business decisions.

Gain key critical insights for VICTOZA:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
Pages

392

Product

VICTOZA

DrugPatentWatch - Make Better Decisions
Scroll to Top